首页> 外文期刊>Ecotoxicology and Environmental Safety >Investigation of pharmaceutically active compounds in an urban receiving water: Occurrence, fate and environmental risk assessment
【24h】

Investigation of pharmaceutically active compounds in an urban receiving water: Occurrence, fate and environmental risk assessment

机译:在接受水的城市中研究药物活性化合物:发生,命运和环境风险评估

获取原文
获取原文并翻译 | 示例
       

摘要

Pharmaceutically active compounds (PhACs) recently have been recognized to constitute a health risk for aquatic ecosystems. The major pathways of PhACs to enter the aquatic environment are excretion and discharge of effluents through sewage treatment plants (STPs). The occurrence, bioaccumulation and risk assessment of lipophilic PhACs, including erythromycin, ketoconazole, indomethacin, diclofenac, gemfibrozil, bezafibrate, propranolol, carbamazepine, sertraline and 17 alpha-ethinylestradiol were investigated in a river that receives effluents from STP. The results indicate that the PhACs were extensively existed in fish, sediment, suspended particulate matter (SPM), colloidal phase (5 kDa to 1 gm) and truly dissolved phase ( 5 kDa) water, with total concentration of ten PhACs (Sigma(10)PhACs) of ND-19.6 ng/g, 7.3-11.2 ng/g, 25.3-101.5 ng/g, 10.1-27.7 ng/L and 67.0-107.6 ng/L, respectively. The Sigma(10)PhACs for particulate and water samples collected from STP's outfall site were higher than those collected from upstream and downstream, indicating that the STP is an important PhACs source of river. However, the Sigma(10)PhACs in sediment showed no significant statistical differences in the sampling area, and which was 3.5-9.5 times lower than those in SPM samples. The colloidal phase contributed 2.5-28.5% of erythromycin, 5.8-45.6% of ketoconazole, 8.4-32.2% of indomethacin, 7.0-21.4% of diclofenac, 11.6-36.9% of gemfibrozil, 10.2-45.9% of bezafibrate, 5.9-16.8% of propranolol, 1.9-11.1% of carbamazepine and 1.1-23.8% of sertraline in the aquatic environment. This suggests that aquatic particulates (e.g., colloids and SPM) maybe an important carrier for PhACs in the aquatic system. In general, the Sigma(10)PhACs in the tissues of fish were in order as follows: kidney brain liver gill muscle. Based on truly dissolved concentrations of PhACs in the water, bioaccumulation factors were between 3.7 and 2727.3 in the fish tissues, sertraline exhibited bioaccumulation potential. In all the risk assessments, erythromycin could cause most harmful adverse health effects for the most sensitive algae group based on the acute and chronic data. In addition, the risk quotient values for diclofenac toward fish were higher than 1. These results indicate that the PhACs pose a potential risk to the aquatic organisms, especially for chronic risk.
机译:最近,人们已经认识到药物活性化合物(PhAC)对水生生态系统构成健康风险。 PhAC进入水生环境的主要途径是通过污水处理厂(STP)的排泄和排放。在一条接受了STP废水的河流中,对包括红霉素,酮康唑,吲哚美辛,双氯芬酸,吉非贝齐,苯扎贝特,普萘洛尔,卡马西平,舍曲林和17种α-乙炔雌二醇在内的亲脂性PhAC的发生,生物蓄积和风险评估进行了研究。结果表明,PhACs广泛存在于鱼类,沉积物,悬浮颗粒物(SPM),胶体相(5 kDa至1 gm)和真正溶解相(<5 kDa)的水中,总浓度为10 PhACs(Sigma( 10)PhACs分别为ND-19.6 ng / g,7.3-11.2 ng / g,25.3-101.5 ng / g,10.1-27.7 ng / L和67.0-107.6 ng / L。从污水处理厂排污口采集的颗粒物和水样的Sigma(10)PhACs高于从上游和下游采集的颗粒物和水样,这表明污水处理厂是河流的重要PhACs来源。但是,沉积物中的Sigma(10)PhACs在采样区域中没有显着的统计差异,比SPM样品低3.5-9.5倍。胶体相贡献了红霉素的2.5-28.5%,酮康唑的5.8-45.6%,吲哚美辛的8.4-32.2%,双氯芬酸的7.0-21.4%,吉非贝齐的11.6-36.9%,苯扎贝特的10.2-45.9%,5.9-16.8%水生环境中普萘洛尔,卡马西平的1.9-11.1%和舍曲林的1.1-23.8%。这表明水生颗粒(例如胶体和SPM)可能是水生系统中PhAC的重要载体。通常,鱼组织中的Sigma(10)PhAC顺序如下:肾脏>脑>肝脏>腮>肌肉。根据水中PhAC的真正溶解浓度,鱼组织中的生物蓄积因子在3.7至2727.3之间,舍曲林具有生物蓄积潜力。在所有风险评估中,根据急性和慢性数据,红霉素可能对最敏感的藻类群造成最有害的不利健康影响。此外,双氯芬酸对鱼类的风险商值高于1。这些结果表明,PhAC对水生生物构成潜在风险,特别是对于慢性风险。

著录项

  • 来源
    《Ecotoxicology and Environmental Safety》 |2018年第6期|214-220|共7页
  • 作者单位

    Hohai Univ, Coll Environm, Key Lab Integrated Regulat & Resources Dev, Nanjing 210098, Jiangsu, Peoples R China;

    Hohai Univ, Coll Environm, Key Lab Integrated Regulat & Resources Dev, Nanjing 210098, Jiangsu, Peoples R China;

    Hohai Univ, Coll Environm, Key Lab Integrated Regulat & Resources Dev, Nanjing 210098, Jiangsu, Peoples R China;

    Hohai Univ, Coll Environm, Key Lab Integrated Regulat & Resources Dev, Nanjing 210098, Jiangsu, Peoples R China;

    Hohai Univ, Coll Environm, Key Lab Integrated Regulat & Resources Dev, Nanjing 210098, Jiangsu, Peoples R China;

    Hohai Univ, Coll Environm, Key Lab Integrated Regulat & Resources Dev, Nanjing 210098, Jiangsu, Peoples R China;

  • 收录信息 美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Pharmaceutically active compounds; Partitioning; Bioaccumulation; Ecological risk;

    机译:药物活性化合物;分配;生物蓄积;生态风险;
  • 入库时间 2022-08-17 13:22:37

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号